Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers V > Headlines for Ventiv Health Inc. > News item |
Jefferies maintains Ventiv Health at buy
Ventiv Health was maintained at buy with a $30 price target by Jefferies & Co. Inc. analysts David Windley and Sumant Kulkarni, who raised the 2005 earnings-per-share estimate to $1.15-$1.17 from $1.09-$1.13 after the company reported strong third-quarter results. Excluding a large tax benefit, Ventiv's earnings per share came in at $0.30, beating estimates by $0.06. Additionally, Ventiv's diversification strategy helped to lever margin, and Jefferies predicted 40% of 2006 profits will come from non-core units. Shares of the Somerset, N.J.-based management services company were up $0.65, or 2.41%, at $27.65 on volume of 870,955 shares versus the three-month running average of 507,005 shares.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.